Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camille Jacques

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Journal of Inflammation Research|December 20, 2022
Special Focus on the Cellular Anti-Inflammatory Effects of Several Micro-Immunotherapy Formulations: Considerations Regarding Intestinal-, Immune-Axis-Related- and Neuronal-Inflammation ContextsCamille Jacques, Ilaria Floris
International Journal of Molecular Sciences|January 21, 2023
How an Immune-Factor-Based Formulation of Micro-Immunotherapy Could Interfere with the Physiological Processes Involved in the Atopic MarchCamille Jacques, Ilaria Floris
Sports (Basel, Switzerland)|June 25, 2026
Perspective: Personalized Management of Oxidative and Nitrosative Stress in Post-Exercise Recovery with a Particular Emphasis on the Potential of Micro-ImmunotherapyCamille Jacques, Ilaria Floris
International Journal of Molecular Sciences|July 2, 2021
Ultra-Low Dose Cytokines in Rheumatoid Arthritis, Three Birds with One Stone as the Rationale of the 2LARTH<sup>®</sup> Micro-Immunotherapy TreatmentCamille Jacques, Ilaria Floris, Béatrice Lejeune
Journal of Inflammation Research|February 26, 2024
Actives from the Micro-Immunotherapy Medicine 2LMIREG<sup>®</sup> Reduce the Expression of Cytokines and Immune-Related Markers Including Interleukin-2 and HLA-II While Modulating Oxidative Stress and Mitochondrial FunctionCamille Jacques, Flora Marchand, Mathias Chatelais, et al.
Journal of Inflammation Research|March 26, 2025
Understanding the Mode of Action of Several Active Ingredients from the Micro-Immunotherapy Medicine 2LZONA<sup>®</sup>Camille Jacques, Flora Marchand, Mathias Chatelais, et al.
Life (Basel, Switzerland)|January 23, 2024
Understanding the Mode of Action of a Micro-Immunotherapy Formulation: Pre-Clinical Evidence from the Study of 2LEBV<sup>®</sup> Active IngredientsCamille Jacques, Flora Marchand, Mathias Chatelais, et al.
International Journal of Molecular Sciences|February 26, 2022
The Unitary Micro-Immunotherapy Medicine Interferon-γ (4 CH) Displays Similar Immunostimulatory and Immunomodulatory Effects than Those of Biologically Active Human Interferon-γ on Various Cell TypesCamille Jacques, Mathias Chatelais, Karim Fekir, et al.
Cancers|April 13, 2024
The Micro-Immunotherapy Medicine 2LPAPI<sup>®</sup> Displays Immune-Modulatory Effects in a Model of Human Papillomavirus Type-16 L1-Protein Capsid-Treated Human Peripheral Blood Mononuclear Cells and Antiproliferative Effects in a Model of Cervical Cancer CellsCamille Jacques, Flora Marchand, Mathias Chatelais, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 8, 2019
Analysis of mRNA, miRNA, and DNA in Bone Cells by RT-qPCR and In Situ HybridizationBrice Moukengue, Jérôme Amiaud, Camille Jacques, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of Inflammation Research|December 20, 2022
Special Focus on the Cellular Anti-Inflammatory Effects of Several Micro-Immunotherapy Formulations: Considerations Regarding Intestinal-, Immune-Axis-Related- and Neuronal-Inflammation ContextsCamille Jacques, Ilaria Floris
International Journal of Molecular Sciences|January 21, 2023
How an Immune-Factor-Based Formulation of Micro-Immunotherapy Could Interfere with the Physiological Processes Involved in the Atopic MarchCamille Jacques, Ilaria Floris
Sports (Basel, Switzerland)|June 25, 2026
Perspective: Personalized Management of Oxidative and Nitrosative Stress in Post-Exercise Recovery with a Particular Emphasis on the Potential of Micro-ImmunotherapyCamille Jacques, Ilaria Floris
International Journal of Molecular Sciences|July 2, 2021
Ultra-Low Dose Cytokines in Rheumatoid Arthritis, Three Birds with One Stone as the Rationale of the 2LARTH<sup>®</sup> Micro-Immunotherapy TreatmentCamille Jacques, Ilaria Floris, Béatrice Lejeune
Journal of Inflammation Research|February 26, 2024
Actives from the Micro-Immunotherapy Medicine 2LMIREG<sup>®</sup> Reduce the Expression of Cytokines and Immune-Related Markers Including Interleukin-2 and HLA-II While Modulating Oxidative Stress and Mitochondrial FunctionCamille Jacques, Flora Marchand, Mathias Chatelais, et al.
Journal of Inflammation Research|March 26, 2025
Understanding the Mode of Action of Several Active Ingredients from the Micro-Immunotherapy Medicine 2LZONA<sup>®</sup>Camille Jacques, Flora Marchand, Mathias Chatelais, et al.
Life (Basel, Switzerland)|January 23, 2024
Understanding the Mode of Action of a Micro-Immunotherapy Formulation: Pre-Clinical Evidence from the Study of 2LEBV<sup>®</sup> Active IngredientsCamille Jacques, Flora Marchand, Mathias Chatelais, et al.
International Journal of Molecular Sciences|February 26, 2022
The Unitary Micro-Immunotherapy Medicine Interferon-γ (4 CH) Displays Similar Immunostimulatory and Immunomodulatory Effects than Those of Biologically Active Human Interferon-γ on Various Cell TypesCamille Jacques, Mathias Chatelais, Karim Fekir, et al.
Cancers|April 13, 2024
The Micro-Immunotherapy Medicine 2LPAPI<sup>®</sup> Displays Immune-Modulatory Effects in a Model of Human Papillomavirus Type-16 L1-Protein Capsid-Treated Human Peripheral Blood Mononuclear Cells and Antiproliferative Effects in a Model of Cervical Cancer CellsCamille Jacques, Flora Marchand, Mathias Chatelais, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 8, 2019
Analysis of mRNA, miRNA, and DNA in Bone Cells by RT-qPCR and In Situ HybridizationBrice Moukengue, Jérôme Amiaud, Camille Jacques, et al.
Pageof 3